AI assistant
Sending…
BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2021
Jun 1, 2021
31868_dirs_2021-06-01_b42a5951-40e4-4250-8317-608e8d9f6cba.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2021-05-28
Reporting Person: INGRAM ROBERT ALEXANDER (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-28 | Common Stock | A | 1188 | $15.77 | Acquired | 76201 | Direct |
Footnotes
F1: Shares of Common Stock issued to the reporting person in lieu of quarterly cash Board Member retainer of $18,750.
More from BIOCRYST PHARMACEUTICALS INC
Regulatory Filings
2026
Jun 29
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 12
Call Transcript
2026
Jun 3
Call Transcript
2026
May 12
Interim / Quarterly Report
2026
May 6
Call Transcript
2026
May 6
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 4
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 23